Metraipolis › archive › dc_0c0293adf8bb
Adjuvant nivolumab and relatlimab in stage III/IV melanoma: the randomized phase 3 RELATIVITY-098 trial — Europe PMC PMID:41109920
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41109920
- DOI
- 10.1038/s41591-[numero omesso]-8
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T05:24:29.904Z
- SHA-256 of the archived text
f5c23190094a876500a201fa67030a35ebf9a58a422164b61f7c88eb1badf862- Stable URL of this page
https://metraipolis.com/documento/dc_0c0293adf8bb
How to cite
Adjuvant nivolumab and relatlimab in stage III/IV melanoma: the randomized phase 3 RELATIVITY-098 trial — Europe PMC PMID:41109920 — Europe PMC (en), https://europepmc.org/article/MED/41109920 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0c0293adf8bb (Metraipolis archive dc_0c0293adf8bb, sha256 f5c23190094a876500a201fa67030a35ebf9a58a422164b61f7c88eb1badf862)
BibTeX
@misc{dc0c0293adf8bb,
title = {Adjuvant nivolumab and relatlimab in stage III/IV melanoma: the randomized phase 3 RELATIVITY-098 trial — Europe PMC PMID:41109920},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41109920},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0c0293adf8bb; sha256 f5c23190094a876500a201fa67030a35ebf9a58a422164b61f7c88eb1badf862},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41109920. Agents can read the archived copy with the MCP tool read_document.